PT3760192T - Gel de cloroquina e método de preparação e aplicação deste - Google Patents

Gel de cloroquina e método de preparação e aplicação deste

Info

Publication number
PT3760192T
PT3760192T PT198929960T PT19892996T PT3760192T PT 3760192 T PT3760192 T PT 3760192T PT 198929960 T PT198929960 T PT 198929960T PT 19892996 T PT19892996 T PT 19892996T PT 3760192 T PT3760192 T PT 3760192T
Authority
PT
Portugal
Prior art keywords
preparation
application therefor
chloroquine gel
chloroquine
gel
Prior art date
Application number
PT198929960T
Other languages
English (en)
Original Assignee
Guangzhou Hybribio Medicine Tech Ltd
Guangzhou Hybribio Biotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Hybribio Medicine Tech Ltd, Guangzhou Hybribio Biotech Ltd filed Critical Guangzhou Hybribio Medicine Tech Ltd
Publication of PT3760192T publication Critical patent/PT3760192T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT198929960T 2018-12-04 2019-11-04 Gel de cloroquina e método de preparação e aplicação deste PT3760192T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811474701.3A CN109288816B (zh) 2018-12-04 2018-12-04 一种氯喹凝胶及其制备方法和应用

Publications (1)

Publication Number Publication Date
PT3760192T true PT3760192T (pt) 2023-02-16

Family

ID=65142502

Family Applications (1)

Application Number Title Priority Date Filing Date
PT198929960T PT3760192T (pt) 2018-12-04 2019-11-04 Gel de cloroquina e método de preparação e aplicação deste

Country Status (12)

Country Link
US (2) US11147773B2 (pt)
EP (1) EP3760192B1 (pt)
JP (1) JP6893288B2 (pt)
KR (1) KR102260231B1 (pt)
CN (1) CN109288816B (pt)
AU (1) AU2019391079B2 (pt)
BR (1) BR112020019266A2 (pt)
ES (1) ES2938738T3 (pt)
PL (1) PL3760192T3 (pt)
PT (1) PT3760192T (pt)
RU (1) RU2760457C1 (pt)
WO (1) WO2020114166A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109288816B (zh) 2018-12-04 2019-11-22 广州凯普医药科技有限公司 一种氯喹凝胶及其制备方法和应用
CN110917196B (zh) * 2020-02-05 2020-06-05 广州康健医学科技有限公司 一种氯喹抑菌消毒液及其应用
EP4135673A4 (en) * 2020-04-14 2024-05-08 Glanis Pharmaceuticals, Inc. TRANSDERMAL AND/OR TOPICAL ADMINISTRATION SYSTEM COMPRISING HYDROXYCHLOROQUINE AND/OR CHLOROQUINE
CN111328811B (zh) * 2020-04-16 2021-07-23 广州康健医学科技有限公司 一种低浓度酒精杀菌消毒液及其应用
CN114044548B (zh) * 2021-09-24 2023-08-11 杭州食疗晶元生物科技有限公司 一种快速降解水凝胶回收水资源的方法
CN114146065A (zh) * 2021-12-14 2022-03-08 合肥工业大学 一种用于选择性对抗炎性细胞的包裹氯喹的变性白蛋白纳米粒子及其制备方法和应用
CN114796126B (zh) * 2022-04-02 2023-04-18 复旦大学附属中山医院青浦分院(上海市青浦区中心医院) 关节腔注射用硫酸羟氯喹缓释微球及其制备方法
CN114848642A (zh) * 2022-07-07 2022-08-05 广州康健医学科技有限公司 磷酸氯喹在制备防治高危型hpv感染及宫颈癌前病变与宫颈癌的药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7309500B2 (en) * 2003-12-04 2007-12-18 The Board Of Trustees Of The University Of Illinois Microparticles
DE102005041860A1 (de) * 2005-09-02 2007-03-08 Schering Ag Nanopartikulärer Einschluss- und Ladungskomplex für pharmazeutische Formulierungen
CN102488659A (zh) * 2011-12-14 2012-06-13 常州市晨光树脂有限公司 一种可载药水溶性壳聚糖纳米粒子的制备方法
CN104703601A (zh) * 2012-07-03 2015-06-10 格雷斯兰生物科技股份有限公司 用于治疗和抑制病毒感染的组合物和方法
US20140011839A1 (en) * 2012-07-03 2014-01-09 Justice E. OBI Compositions and methods for treating and inhibiting viral infections
US20150303461A1 (en) * 2013-10-23 2015-10-22 Lin-Feng Li Composite materials for rechargeable zinc electrodes
CN108671231B (zh) * 2018-08-06 2020-07-10 合肥工业大学 一种用于肿瘤光热增效治疗和超声成像的多功能纳米载体及制备方法
CN109288816B (zh) * 2018-12-04 2019-11-22 广州凯普医药科技有限公司 一种氯喹凝胶及其制备方法和应用

Also Published As

Publication number Publication date
EP3760192A1 (en) 2021-01-06
US20200397713A1 (en) 2020-12-24
KR20200113277A (ko) 2020-10-06
WO2020114166A1 (zh) 2020-06-11
JP2021509681A (ja) 2021-04-01
US20210401763A1 (en) 2021-12-30
EP3760192B1 (en) 2023-01-18
AU2019391079B2 (en) 2021-09-23
RU2760457C1 (ru) 2021-11-25
CN109288816B (zh) 2019-11-22
BR112020019266A2 (pt) 2021-01-05
US11564891B2 (en) 2023-01-31
ES2938738T3 (es) 2023-04-14
PL3760192T3 (pl) 2023-03-20
AU2019391079A1 (en) 2020-09-24
KR102260231B1 (ko) 2021-06-03
US11147773B2 (en) 2021-10-19
JP6893288B2 (ja) 2021-06-23
EP3760192A4 (en) 2021-11-17
CN109288816A (zh) 2019-02-01

Similar Documents

Publication Publication Date Title
PT3760192T (pt) Gel de cloroquina e método de preparação e aplicação deste
ZA202001447B (en) M-diamide compound and preparation method therefor and use thereof
EP3836688A4 (en) RESOURCE CONFIGURATION PROCEDURE AND DEVICE
EP3823364A4 (en) CONFIGURATION PROCESS AND DEVICE
EP3547163A4 (en) METHOD AND DEVICE FOR TRANSLATION
EP3817507A4 (en) CONFIGURATION PROCEDURE AND DEVICE
HUE062343T2 (hu) Felhordó berendezés és a hozzá tartozó alkalmazási eljárás
EP3863347A4 (en) Resource configuration method and device
EP3852348A4 (en) TRANSLATION PROCEDURE AND TERMINAL DEVICE
GB201905559D0 (en) Composition and method
GB201915949D0 (en) Biosensor preparation method and system
IL279552A (en) The hemostatic composition and method for its preparation
EP3903796A4 (en) PREPARATION OF CARDIOMYOCYTES, METHOD FOR PREPARATION AND USE
EP3806394A4 (en) CONFIGURATION PROCEDURE AND DEVICE
EP3429018A4 (en) Gel electroporation and method of preparation therefor
GB202102862D0 (en) Water-containing lipstick and preparation method therefor
EP3653202A4 (en) PHARMACEUTICAL PREPARATION AND MANUFACTURING PROCESSES FOR IT
EP3845502A4 (en) BENDING DEVICE AND BENDING PROCESS
EP3429017A4 (en) GEL ELECTROLYTE AND MANUFACTURING METHOD THEREFOR
GB201909542D0 (en) Composition and method
EP3786156C0 (en) 10H-PHENOTHIAZINE FERROPTOSE INHIBITOR AND METHOD OF PREPARING THE SAME AND USE THEREOF
EP3771250A4 (en) CONFIGURATION PROCEDURE AND DEVICE
EP3876627A4 (en) RESOURCE CONFIGURATION METHOD AND DEVICE
EP3882284A4 (en) ACRYLAMIDE COPOLYMER AND PROCESSES FOR PRODUCTION THEREOF AND USE THEREOF
EP3582120A4 (en) TRANSLATION DEVICE AND TRANSLATION METHOD